{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T15:33:33Z","timestamp":1793028813695,"version":"4.5.0"},"reference-count":61,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Telomere maintenance-related genes (TMRGs) are implicated in Colorectal cancer (CRC) development, but their prognostic value and clinical relevance remain insufficiently explored. This study aims to develop a TMRG-based prognostic model and elucidate its clinical utility in CRC management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The Cancer Genome Atlas database was utilized to download RNA-seq data from 638 CRC and 51 control samples. Differential expressed genes were screened and intersected with 2086 TMRGs, resulting in the identification of 976 TMRGs. Through univariate and multivariate Cox regression analysis, a prognostic model comprising three telomere maintenance-related biomarkers (\n                      <jats:italic>PDE1B, TFAP2B, and HSPA1A<\/jats:italic>\n                      ) was developed and validated using an external dataset. By integrating the model risk score with clinical features, a nomogram was constructed to predict the survival outcomes of CRC patients. Additionally, an in-depth investigation of the immuno-infiltration, functional variation and drug sensitivity analysis were performed in two risk subgroups defined by the prognostic model. Finally, the functional significance of\n                      <jats:italic>PDE1B<\/jats:italic>\n                      in CRC cell lines was investigated through MTT assays, cell colony formation assays, transwell assays and flow cytometry.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 976 DE-TMRGs were enriched in telomere\/DNA replication pathways. A three-gene signature (PDE1B, TFAP2B, and HSPA1A) stratified patients into high- and low-risk groups with divergent survival (AUC &amp;gt;0.60, validated externally). High-risk patients had advanced N\/M stages, elevated M0\/M2 macrophages, reduced CD4\n                      <jats:sup>+<\/jats:sup>\n                      memory T cells, and upregulated immune checkpoints. Nomogram integrating risk score, age, and N\/M stage accurately predicted 1-\/3-\/5-year survival. Low-risk patients showed greater 5-fluorouracil sensitivity.\n                      <jats:italic>PDE1B<\/jats:italic>\n                      expression was significantly reduced in CRC tissues and correlated with advanced stages. Functional assays confirmed PDE1B overexpression suppressed proliferation, migration, invasion, and induced apoptosis in CRC cells.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      This study identifies a moderately predictive telomere maintenance-related gene signature as an independent prognostic predictor in CRC. The risk stratification model effectively discriminates patients with distinct survival patterns, tumor microenvironments, and therapeutic responses, while the integrated nomogram offers additional reference information for survival analysis, albeit with only moderate predictive accuracy. These findings indicate telomere maintenance-related gene signature could serve as a preliminary auxiliary risk stratification tool for postoperative CRC patients,\n                      <jats:italic>PDE1B<\/jats:italic>\n                      may also serve as a potential epithelial tumor-suppressor target for future preclinical studies.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmolb.2026.1728178","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:53:26Z","timestamp":1787921606000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Crucial role of telomere maintenance-related genes in survival prediction and subtype identification in colorectal cancer"],"prefix":"10.3389","volume":"13","author":[{"given":"Feng","family":"Huang","sequence":"first","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, UCSI University","place":["Kuala Lumpur, Malaysia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Yin","family":"Fong","sequence":"additional","affiliation":[{"name":"Faculty of Applied Sciences, UCSI University","place":["Kuala Lumpur, Malaysia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin Tat","family":"Ng","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University Kebangsaan Malaysia","place":["Kuala Lumpur, Malaysia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthikkumar","family":"Venkatachalam","sequence":"additional","affiliation":[{"name":"Centre for Cancer Prevention and Drug Development, Department of Internal Medicine, Hematology-Oncology Section, University of Oklahoma Health Sciences Centre","place":["Oklahoma City, OK, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Abdullah","family":"Alshawsh","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Nursing and Health Sciences, Monash University","place":["Clayton, VIC, Australia"]},{"name":"Department of Pharmacology, Faculty of Medicine, Universiti Malaya","place":["Kuala Lumpur, Malaysia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Wai","family":"Mai","sequence":"additional","affiliation":[{"name":"Centre for Cancer and Stem Cell Research, Institute of Research, Development and Innovation (IRDI) IMU University","place":["Kuala Lumpur, Malaysia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yik-Ling","family":"Chew","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, UCSI University","place":["Kuala Lumpur, Malaysia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malarvili","family":"Selvaraja","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, UCSI University","place":["Kuala Lumpur, Malaysia"]},{"name":"Department of Structural and Cellular Biology, Tulane University School of Medicine","place":["New Orleans, LA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1152\/physrev.1995.75.4.725","article-title":"Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms","volume":"75","author":"Beavo","year":"1995","journal-title":"Physiol. Rev."},{"key":"B2","doi-asserted-by":"publisher","first-page":"926","DOI":"10.3390\/bios13100926","article-title":"Current status and emerging trends in colorectal cancer screening and diagnostics","volume":"13","author":"Beniwal","year":"2023","journal-title":"Biosens. (Basel)."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1126\/science.aab3389","article-title":"Human telomere biology: a contributory and interactive factor in aging, disease risks, and protection","volume":"350","author":"Blackburn","year":"2015","journal-title":"Science"},{"key":"B5","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1101\/gad.353122.125","article-title":"Telomeres at the nexus of aging, tumor suppression, and inflammation: toward an understanding beyond senescence","volume":"39","author":"Bloom","year":"2025","journal-title":"Genes Dev."},{"key":"B6","doi-asserted-by":"publisher","first-page":"104920","DOI":"10.1016\/j.ebiom.2023.104920","article-title":"Analysis of multiple programmed cell death-related prognostic genes and functional validations of necroptosis-associated genes in oesophageal squamous cell carcinoma","volume":"99","author":"Cao","year":"2024","journal-title":"EBioMedicine"},{"key":"B8","doi-asserted-by":"publisher","first-page":"13790","DOI":"10.1038\/s41598-024-64627-y","article-title":"PDE1B, a potential biomarker associated with tumor microenvironment and clinical prognostic significance in osteosarcoma","volume":"14","author":"Chen","year":"2024","journal-title":"Sci. Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"940073","DOI":"10.3389\/fgene.2022.940073","article-title":"Inhibition of ABL1 by tyrosine kinase inhibitors leads to a downregulation of MLH1 by Hsp70-mediated lysosomal protein degradation","volume":"13","author":"Daniels","year":"2022","journal-title":"Front. Genet."},{"key":"B10","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1126\/science.1170633","article-title":"How telomeres solve the end-protection problem","volume":"326","author":"de Lange","year":"2009","journal-title":"Science"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","article-title":"Colorectal cancer","volume":"394","author":"Dekker","year":"2019","journal-title":"Lancet."},{"key":"B12","doi-asserted-by":"publisher","first-page":"3252","DOI":"10.1038\/onc.2016.469","article-title":"PDE4D promotes FAK-mediated cell invasion in BRAF-mutated melanoma","volume":"36","author":"Delyon","year":"2017","journal-title":"Oncogene"},{"key":"B13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13046-021-02229-6","article-title":"ROS\/PI3K\/Akt and Wnt\/\u03b2-catenin signalings activate HIF-1\u03b1-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer","volume":"41","author":"Dong","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s11658-025-00808-5","article-title":"lncRNA IGFL2-AS1 mediates NSCLC chemoresistance via YBX1-induced HSPA1A\/RAP1 activation","volume":"30","author":"Dong","year":"2025","journal-title":"Cell Mol. Biol. Lett."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e69240","DOI":"10.1371\/journal.pone.0069240","article-title":"Berberine targets AP-2\/hTERT, NF-\u03baB\/COX-2, HIF-1\u03b1\/VEGF and Cytochrome-c\/Caspase signaling to suppress human cancer cell growth","volume":"8","author":"Fu","year":"2013","journal-title":"PLoS One"},{"key":"B16","doi-asserted-by":"publisher","first-page":"7717","DOI":"10.1158\/1078-0432.CCR-08-0827","article-title":"Targeted inhibition of cyclic AMP phosphodiesterase-4 promotes brain tumor regression","volume":"14","author":"Goldhoff","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"749673","DOI":"10.3389\/fonc.2021.749673","article-title":"Upregulation of HSPA1A\/HSPA1B\/HSPA7 and downregulation of HSPA9 were related to poor survival in Colon cancer","volume":"11","author":"Guan","year":"2021","journal-title":"Front. Oncol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"134678","DOI":"10.1016\/j.neulet.2019.134678","article-title":"HSP70 and HSP90 in neurodegenerative diseases","volume":"716","author":"Gupta","year":"2020","journal-title":"Neurosci. Lett."},{"key":"B19","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"B20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinforma."},{"key":"B21","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/346866a0","article-title":"Telomere reduction in human colorectal carcinoma and with ageing","volume":"346","author":"Hastie","year":"1990","journal-title":"Nature"},{"key":"B22","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s12672-025-04262-9","article-title":"Prognostic value of brown adipocyte-related genes in colorectal cancer: a multi-omics and Mendelian randomization study","volume":"17","author":"He","year":"2025","journal-title":"Discov. Oncol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.7314\/apjcp.2013.14.6.3987","article-title":"What is a cancer cell? Why does it metastasize?","volume":"14","author":"Hegde","year":"2013","journal-title":"Asian Pac J. Cancer Prev."},{"key":"B24","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/sj.onc.1205058","article-title":"Alternative lengthening of telomeres in mammalian cells","volume":"21","author":"Henson","year":"2002","journal-title":"Oncogene"},{"key":"B25","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1128\/mcb.24.2.899-911.2004","article-title":"Genomic instability and enhanced radiosensitivity in Hsp70.1- and Hsp70.3-deficient mice","volume":"24","author":"Hunt","year":"2004","journal-title":"Mol. Cell Biol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"441","DOI":"10.4097\/kja.19183","article-title":"Survival analysis: part II - applied clinical data analysis","volume":"72","author":"In","year":"2019","journal-title":"Korean J. Anesthesiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3389\/fnins.2017.00254","article-title":"The Hsp70\/Hsp90 chaperone machinery in neurodegenerative diseases","volume":"11","author":"Lackie","year":"2017","journal-title":"Front. Neurosci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/diseases9010021","article-title":"Diagnostic and prognostic value of CEA and CA19-9 in colorectal cancer","volume":"9","author":"Lakemeyer","year":"2021","journal-title":"Diseases"},{"key":"B32","doi-asserted-by":"publisher","first-page":"975057","DOI":"10.3389\/fimmu.2022.975057","article-title":"Telomere-related gene risk model for prognosis and drug treatment efficiency prediction in kidney cancer","volume":"13","author":"Li","year":"2022","journal-title":"Front. Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"116172","DOI":"10.1016\/j.biopha.2024.116172","article-title":"Astragalus polysaccharide ameliorates CD8(+) T cell dysfunction through STAT3\/Gal-3\/LAG3 pathway in inflammation-induced colorectal cancer","volume":"171","author":"Li","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.18632\/oncotarget.6407","article-title":"Melatonin inhibits AP-2\u03b2\/hTERT, NF-\u03baB\/COX-2 and Akt\/ERK and activates caspase\/Cyto C signaling to enhance the antitumor activity of berberine in lung cancer cells","volume":"7","author":"Lu","year":"2016","journal-title":"Oncotarget"},{"key":"B35","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.pharmthera.2005.07.003","article-title":"Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents","volume":"109","author":"Lugnier","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"B36","doi-asserted-by":"publisher","first-page":"7985","DOI":"10.18632\/aging.103117","article-title":"PHLDA2 regulates EMT and autophagy in colorectal cancer via the PI3K\/AKT signaling pathway","volume":"12","author":"Ma","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"B37","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s10238-025-01913-7","article-title":"Decoding colorectal cancer chemotherapy and immunotherapy resistance: revealing the role of NOL3 using single-cell RNA sequencing and machine learning","volume":"26","author":"Ma","year":"2025","journal-title":"Clin. Exp. Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"282","DOI":"10.2174\/0115680266397024250710105241","article-title":"Telomere maintenance characteristics predict prognosis and therapeutic response in colorectal cancer","volume":"26","author":"Ma","year":"2026","journal-title":"Curr. Top. Med. Chem."},{"key":"B50","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1158\/2159-8290.CD-16-1050","article-title":"TERT promoter mutations enhance telomerase activation by long-range chromatin interactions","volume":"6","author":"Min","year":"2016","journal-title":"Cancer Discov"},{"key":"B40","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods."},{"key":"B41","doi-asserted-by":"publisher","first-page":"6622","DOI":"10.1073\/pnas.85.18.6622","article-title":"A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes","volume":"85","author":"Moyzis","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B42","doi-asserted-by":"crossref","first-page":"a041688","DOI":"10.1101\/cshperspect.a041688","article-title":"Telomere crisis shapes cancer evolution","volume":"18","author":"Nassour","year":"2026","journal-title":"Cold Spring Harb. Perspect. Biol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat. Methods"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3390\/cells8020107","article-title":"Revisiting telomere shortening in cancer","volume":"8","author":"Okamoto","year":"2019","journal-title":"Cells"},{"key":"B45","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/labinvest.2017.106","article-title":"Lobular carcinoma in situ and invasive lobular breast cancer are characterized by enhanced expression of transcription factor AP-2\u03b2","volume":"98","author":"Raap","year":"2018","journal-title":"Lab. Invest"},{"key":"B47","doi-asserted-by":"publisher","first-page":"829059","DOI":"10.3389\/fonc.2022.829059","article-title":"Inhibition of angiogenesis and extracellular matrix remodeling: synergistic effect of renin-angiotensin system inhibitors and bevacizumab","volume":"12","author":"Ren","year":"2022","journal-title":"Front. Oncol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1136\/gutjnl-2014-309086","article-title":"Colorectal cancer screening: a global overview of existing programmes","volume":"64","author":"Schreuders","year":"2015","journal-title":"Gut"},{"key":"B51","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41576-019-0099-1","article-title":"Telomeres and telomerase: three decades of progress","volume":"20","author":"Shay","year":"2019","journal-title":"Nat. Rev. Genet."},{"key":"B52","doi-asserted-by":"publisher","first-page":"5541","DOI":"10.1073\/pnas.0408454102","article-title":"Structural and numerical chromosome changes in colon cancer develop through telomere-mediated anaphase bridges, not through mitotic multipolarity","volume":"102","author":"Stew\u00e9nius","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B53","first-page":"1245","article-title":"Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions","volume":"1","author":"Tahara","year":"1995","journal-title":"Clin. Cancer Res."},{"key":"B54","doi-asserted-by":"publisher","first-page":"6646459","DOI":"10.1155\/2021\/6646459","article-title":"Identification and analysis of three hub prognostic genes related to osteosarcoma metastasis","volume":"2021","author":"Tan","year":"2021","journal-title":"J. Oncol."},{"key":"B55","first-page":"2696","article-title":"High telomerase activity is an independent prognostic indicator of poor outcome in colorectal cancer","volume":"6","author":"Tatsumoto","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"B56","doi-asserted-by":"publisher","first-page":"7444","DOI":"10.1158\/1078-0432.CCR-08-0478","article-title":"Relationship between tumor and plasma levels of hTERT mRNA in patients with colorectal cancer: implications for monitoring of neoplastic disease","volume":"14","author":"Terrin","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"B57","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.17305\/bb.2025.12053","article-title":"Role of telomere maintenance genes as a predictive biomarker for colorectal cancer immunotherapy response and prognosis","volume":"25","author":"Wang","year":"2025","journal-title":"Biomol. Biomed."},{"key":"B59","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1001\/jama.2010.897","article-title":"Telomere length and risk of incident cancer and cancer mortality","volume":"304","author":"Willeit","year":"2010","journal-title":"Jama"},{"key":"B60","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.ygyno.2018.03.057","article-title":"Decreased expression of TFAP2B in endometrial cancer predicts poor prognosis: a study based on TCGA data","volume":"149","author":"Wu","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.canlet.2011.11.020","article-title":"Extracellular HSPA1A promotes the growth of hepatocarcinoma by augmenting tumor cell proliferation and apoptosis-resistance","volume":"317","author":"Wu","year":"2012","journal-title":"Cancer Lett."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1087246","DOI":"10.3389\/fgene.2022.1087246","article-title":"Telomere maintenance-related genes are important for survival prediction and subtype identification in bladder cancer","volume":"13","author":"Xiao","year":"2023","journal-title":"Front. Genet."},{"key":"B63","doi-asserted-by":"publisher","first-page":"107271","DOI":"10.1016\/j.phrs.2024.107271","article-title":"Dual inhibitors of DNMT and HDAC remodels the immune microenvironment of colorectal cancer and enhances the efficacy of anti-PD-L1 therapy","volume":"206","author":"Yang","year":"2024","journal-title":"Pharmacol. Res."},{"key":"B64","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41420-021-00451-x","article-title":"A novel defined pyroptosis-related gene signature for predicting the prognosis of ovarian cancer","volume":"7","author":"Ye","year":"2021","journal-title":"Cell Death Discov."},{"key":"B65","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12967-025-07261-0","article-title":"Identification and evaluation of glutamine-related gene characteristics based on multi-omics to predict the prognosis of patients with colorectal cancer","volume":"24","author":"Yin","year":"2026","journal-title":"J. Transl. Med."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1002\/cac2.70047","article-title":"Targeting SPHK1 in macrophages remodels the tumor microenvironment and enhances anti-PD-1 immunotherapy efficacy in colorectal cancer liver metastasis","volume":"45","author":"Zhan","year":"2025","journal-title":"Cancer Commun. (Lond)."},{"key":"B68","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1097\/cad.0000000000001078","article-title":"miR-5701 promoted apoptosis of clear cell renal cell carcinoma cells by targeting phosphodiesterase-1B","volume":"32","author":"Zhao","year":"2021","journal-title":"Anticancer Drugs"},{"key":"B69","doi-asserted-by":"publisher","first-page":"19858","DOI":"10.1038\/s41598-025-05556-2","article-title":"Development of a prognostic model for chemotherapy response and identification of TNFAIP2 as a target in colorectal cancer","volume":"15","author":"Zhou","year":"2025","journal-title":"Sci. Rep."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1583327","DOI":"10.3389\/fimmu.2025.1583327","article-title":"Tumor-infiltrating immune cell signature score reveals prognostic biomarkers and therapeutic targets for colorectal cancer","volume":"16","author":"Zuo","year":"2025","journal-title":"Front. Immunol."}],"updated-by":[{"DOI":"10.3389\/fmolb.2026.2013379","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T00:00:00Z","timestamp":1792972800000}}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2026.1728178\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T14:45:35Z","timestamp":1793025935000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2026.1728178\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":61,"alternative-id":["10.3389\/fmolb.2026.1728178"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2026.1728178","relation":{},"ISSN":["2296-889X"],"issn-type":[{"value":"2296-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]},"article-number":"1728178"}}